Join the club for FREE to access the whole archive and other member benefits.

Royal Marsden NHS Foundation Trust

Hospital dedicated to cancer diagnosis, treatment, research and education.

The Royal Marsden is a world-leading cancer centre specialising in cancer diagnosis, treatment, research and education.

We have two hospitals: one in Chelsea, London, and another in Sutton, Surrey. Also in Surrey, we have a Medical Daycare Unit in Kingston.

We are also partners with The Institute of Cancer Research. Through this partnership, we undertake groundbreaking research into new cancer drug therapies and treatments. The partnership makes us the biggest and most comprehensive cancer centre in Europe, with a combined staff of 3,500.

Visit website: https://www.royalmarsden.nhs.uk/

 royalmarsdenchelsea

 the-royal-marsden-nhs-foundation-trust

 royalmarsdenNHS

See also: Company NHS - UK National Health Service, publicly funded healthcare system in England

Details last updated 27-Oct-2019

People at Royal Marsden NHS Foundation Trust

David Cunningham

Consultant Medical Oncologist and Director of Clinical Research at The Royal Marsden in London and Surrey.

John Butler

Consultant Gynaecological Oncology Surgeon at Royal Marsden Hospital.

Julia Chisholm

Paediatric Oncologist at Royal Marsden Hospital.

James Larkin

Consultant Medical Oncologist at Royal Marsden NHS Foundation Trust.

Royal Marsden NHS Foundation Trust News

AI can predict how early breast cancer patients might respond to their treatments

AI can predict how early breast cancer patients might respond to their treatments

Durham University - 09-Feb-2024

This could lead to more personalised treatment plans and better outcomes

Genetically modified virus killed cancer cells in early human trials

Genetically modified virus killed cancer cells in early human trials

BBC - 23-Sep-2022

Weakened form of herpes virus showed promising results for various advanced cancers

New missile-like radioactive therapy treats prostate cancer

New missile-like radioactive therapy treats prostate cancer

The Institute of Cancer Research (ICR) - 03-Jun-2021

Precisely targeted therapy shrank tumours and extends life by 38% in men

New cancer drug shrinks tumour in phase 1 trial

New cancer drug shrinks tumour in phase 1 trial

BBC - 23-Jun-2020

Indeed a new precision approach sparing healthy cells

A new and innovative way of delivering targeted chemotherapy to cancer tumours

A new and innovative way of delivering targeted chemotherapy to cancer tumours

BBC - 18-Dec-2019

Improving effectiveness with reduced side effects - fingers crossed for this first-in-person trial

An effective immunotherapy for advanced prostate cancer

An effective immunotherapy for advanced prostate cancer

BBC - 28-Nov-2019

Only 5% saw their tumours shrink, but may be more successful if used earlier

Pembrolizumab: effective immunotherapy for advanced head and neck cancer

Pembrolizumab: effective immunotherapy for advanced head and neck cancer

BBC - 23-Nov-2019

Needs to identify those who will respond to treatment before starting immunotherapy

Skin cancer survival rate up jumps 10-fold in just 10 years

Skin cancer survival rate up jumps 10-fold in just 10 years

BBC - 28-Sep-2019

UK doctors announce that more than half of the patients can now survive advanced melanoma

A real shift in cancer treatment

A real shift in cancer treatment

BBC - 23-Sep-2019

New drugs present precision medicine, they are based on the genetic make-up of each patient's tumour

New prostate cancer treatment for previously incurable men

New prostate cancer treatment for previously incurable men

Telegraph - 26-Sep-2017

Highly targeted form of radiotherapy shapes radiation beams to tumours. When prostate cancer has...

Topics mentioned on this page:
Cancer